Meribank Biotech Co., Ltd. (4724)
Market Closed
16 Oct, 05:30 AM
TWSE TWSE Primary NT$
9. 67
+0.17
+1.7895%
NT$
1.47B Market Cap
- P/E Ratio
- Div Yield
78,560 Volume
- Eps
NT$ 9.5
Previous Close Want to track 4724 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Meribank Biotech Co., Ltd. (4724) Statistics
Valuation metrics
Market Cap 1.47B
Enterprise value 2.01B
Trailing P/E (ttm) -7.19
Forward P/E -
PEG ratio 0.11
Price/Sales (ttm) 2.43
Price/Book (mrq) 0.84
Enterprise Value/Revenue 4.92
Enterprise Value/EBITDA 35.02
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 161.79K
Average volume (90 days) 87.52K
Price summary
52-Week low 7.94
52-Week high 19.3
Beta -
50-Day moving average 9.24
200-Day moving average 10.86
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -0.33%
Operating margin -0.26%
Operational effectiveness
Return on assets -0.05%
Return on equity -0.11%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 4.26
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.41
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 1.99
Total debt (mrq) -
Total Debt/Equity (mrq) 0.92
Current ratio (mrq) 1.7%
Book value per share (mrq) 12.38
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
